This trial is evaluating whether Treatment will improve 3 primary outcomes and 4 secondary outcomes in patients with Stroke. Measurement will happen over the course of Day 1, after each of the three biofeedback interface sessions.
This trial requires 12 total participants across 0 different treatment group
Patients from any state can participate in this trial, so long as they are able to attend all treatment sessions.
In order to understand how insurance coverage works for this trial, you will need to contact the study coordinator.